---
type: "Nootropic"
title: "Phenylpiracetam"
description: "Phenylpiracetam is a synthetic racetam. Stimulant and memory mechanisms have been studied in animals; cognitive superiority or a safe cycling regimen in healthy people has not been established."
resource: "https://nootropikler.com/nootropics/phenylpiracetam"
tags: ["racetam"]
timestamp: 2026-11-11T00:00:00Z
category: "Energy"
source: "synthetic"
latin: "Phenylpiracetam - Phenotropil / Carphedon"
language: "en"
---

# Phenylpiracetam

*Phenylpiracetam - Phenotropil / Carphedon*

Phenylpiracetam is a synthetic racetam. Stimulant and memory mechanisms have been studied in animals; cognitive superiority or a safe cycling regimen in healthy people has not been established.

## Quick profile

| Property | Value |
| --- | --- |
| Onset of Effect | No established timeframe |
| Effect Duration | No established timeframe |
| Dose used in research | No established clinical dose |
| Tolerance | Not clinically established |

> Correction · 2026-11-11. Sources were added for the mouse findings and WADA classification. Unsupported claims about clinical superiority, mechanisms and adverse-effect frequency were removed.

## What is Phenylpiracetam?

Phenylpiracetam is a synthetic racetam. Stimulant and memory mechanisms have been studied in animals; cognitive superiority or a safe cycling regimen in healthy people has not been established.

## Mechanism of Effect

Zvejniece et al. (2011) compared R and S phenylpiracetam enantiomers in mice; memory responses differed by isomer. This preclinical trial does not establish 20–60-fold superiority to piracetam in humans or clinical benefits via DAT/NET.

## Clinical Evidence

The experiment compared R and S isomers in mice. It does not establish effective human doses, adverse-effect rates or tolerance duration.

WADA’s 2026 list prohibits fonturacetam [4-phenylpiracetam (carphedon)] in competition under S6.A stimulants. A prohibited-list entry is not evidence of clinical efficacy or safety in healthy people.

> **⚠ Tolerance and Limited Evidence Warning:** There is insufficient clinical evidence that a particular break or cycling schedule prevents tolerance or improves efficacy and safety.

## Dose information and research limits

This dose information describes research or product context; it is not a personal prescription, established safe upper limit or efficacy guarantee for healthy people. Extracts and different formulations should not be treated as equivalent milligram for milligram.

## Safety and Side Effects

The animal experiment reviewed here does not establish human adverse-effect or interaction rates for phenylpiracetam. A validated personal dose or cycling protocol is unavailable.


## Frequently Asked Questions

### What does phenylpiracetam do?

Phenylpiracetam is a synthetic racetam. Stimulant and memory mechanisms have been studied in animals; cognitive superiority or a safe cycling regimen in healthy people has not been established.

### What is the recommended dose for phenylpiracetam and how should it be taken?

There is insufficient clinical evidence that a particular break or cycling schedule prevents tolerance or improves efficacy and safety.

### What are the side effects of Phenylpiracetam?

The animal experiment reviewed here does not establish human adverse-effect or interaction rates for phenylpiracetam. A validated personal dose or cycling protocol is unavailable.

### Is phenylpiracetam legal in Türkiye and how can it be obtained?

Sale and import status in Türkiye must be checked for the specific product. Verify supplement approval in the Ministry of Agriculture and Forestry GGBS list, and medicine authorization and conditions of use in TİTCK records. Online availability does not establish approval or unrestricted personal import; current Ministry of Trade conditions apply to postal and express shipments.

### When does the effect of phenylpiracetam begin and how long does it last?

No established timeframe

## Sources

- Malykh AG & Sadaie MR (2010). Piracetam and piracetam-like drugs: from basic science to novel clinical applications to CNS disorders. *Drugs*, 70(3), 287–312. [PubMed · PMID 20166767](https://pubmed.ncbi.nlm.nih.gov/20166767/)
- Zvejniece L, et al. (2011). Investigation into stereoselective pharmacological activity of phenotropil. *Basic & Clinical Pharmacology & Toxicology*, 109(5), 407–412. [PubMed · PMID 21689376](https://pubmed.ncbi.nlm.nih.gov/21689376/)
- World Anti-Doping Agency. The 2026 Prohibited List. https://www.wada-ama.org/sites/default/files/2025-09/2026list_en_final_clean_september_2025.pdf [World Anti-Doping Agency](https://www.wada-ama.org/sites/default/files/2025-09/2026list_en_final_clean_september_2025.pdf)

## Related nootropics

- [Piracetam](/okf/nootropics/piracetam.md)
- [noopept](/okf/nootropics/noopept.md)
- [rhodiola rosea](/okf/nootropics/rhodiola-rosea.md)
